SG Americas Securities
BNGO icon

SG Americas Securities’s Bionano Genomics BNGO Stock Holding History

SG Americas Securities’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-240
Closed -$160K – 2356
2023
Q1 		$160K Buy
240
+21
+10% +$18.7K ﹤0.01% 2588
2022
Q4 		$192K Sell
219
-11
-5% -$13.8K ﹤0.01% 2222
2022
Q3 		$253K Buy
230
+52
+29% +$68.7K ﹤0.01% 2121
2022
Q2 		$147K Buy
178
+157
+748% +$162K ﹤0.01% 2882
2022
Q1 		$32K Sell
21
-51
-71% -$68.8K ﹤0.01% 2869
2021
Q4 		$130K Sell
72
-105
-59% -$281K ﹤0.01% 2908
2021
Q3 		$583K Buy
177
+153
+638% +$535K ﹤0.01% 2361
2021
Q2 		$106K Buy
+24
New +$94.8K ﹤0.01% 2636

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's BNGO Position: Q2 2023 in Review

SG Americas Securities sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 240 shares — an estimated $160K sold.

SG Americas Securities first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $583K in Q3 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • SG Americas Securities reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 240 Bionano Genomics shares in Q2 2023, an estimated $160K.
  • SG Americas Securities first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • SG Americas Securities's Bionano Genomics position peaked at $583K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.